Cryotherapy is the therapeutic use of extreme cold to destroy abnormal or diseased tissue, relieve pain, or reduce inflammation. In its destructive form (cryosurgery / cryoablation), a cryogen — most commonly liquid nitrogen (≈ −196 °C), argon gas, or nitrous oxide — is applied via a probe, spray, or catheter to freeze targeted tissue; ice-crystal formation, cell-membrane rupture, and ischemic necrosis from microvascular thrombosis produce controlled cell death. In its non-destructive form (cold therapy, cryoanesthesia), lower-intensity cooling is used analgesically to blunt nerve conduction and inflammation (e.g., ice packs, whole-body cryotherapy, cold-air devices). The technique is therapeutic by definition — it is an intervention, not a pathological process — and spans many specialties: dermatology (warts, actinic keratoses, skin lesions), oncology (prostate, renal, hepatic, and bone tumors), gynecology (cervical dysplasia), ophthalmology (retinal tears, retinoblastoma), and cardiology (cryoablation for arrhythmias). It is most often confused with electrocautery and radiofrequency ablation, which achieve similar tissue destruction through heat rather than cold, and with simple cryopreservation, which uses cold to preserve (not destroy) cells and tissue.
“icy cold, frost” — combining form denoting cold or freezing
-therapy
Greek θεραπεία (therapeía) (thair-ah-PY-ah), from therapeuein “to treat, attend to”
Noun-forming suffix — “treatment, healing, or therapeutic intervention”
-surgery(alternate compound)
Greek χειρουργία (cheirourgía), from cheir “hand” + ergon “work"
"handwork / operative treatment” — used in the synonym cryosurgery
The word entered medical English in the 20th century (the modern cryotherapy sense is generally dated to the early 1900s, with cryosurgery popularized in the 1960s following the development of the liquid-nitrogen cryoprobe by Irving Cooper and Arnold Lee). It is built from Greek krýos (“icy cold”) + -therapy (“treatment”) — literally “treatment by cold.” The root cry/o- (“cold”) connects cryotherapy to the entire o- root family: cryosurgery (cold + handwork → surgical destruction by freezing), cryoablation (cold + removal → destruction of tissue by freezing), cryopreservation (cold + preservation → preserving cells/tissue by freezing), and cryoglobulin (cold + globulin → proteins that precipitate in cold). The suffix -therapy is highly productive in clinical terminology, appearing in chemotherapy, radiotherapy, phototherapy, hydrotherapy, and immunotherapy.
🔀 ALIASES / ALTERNATE TERMS
Cryosurgery(adjective/noun form — the destructive surgical application; appears as “cryosurgical destruction,” “cryosurgical ablation of lesion”)
Cryoablation(clinical synonym emphasizing tissue removal/destruction; standard term in oncology and cardiology — e.g., “renal cryoablation,” “cardiac cryoablation”)
Cold therapy(lay and clinical term for the non-destructive analgesic/anti-inflammatory form; ice packs, cold compresses, whole-body cryotherapy)
Cryoanesthesia(define briefly — use of localized cold to numb tissue prior to or during a procedure)
Cryodestruction(clinical descriptor synonym for the tissue-destroying intent; used interchangeably with cryosurgery)
Liquid nitrogen therapy(names the most common cryogen; routine in dermatology for warts/actinic keratoses)
Cryospray / spray cryotherapy(delivery-method subtype — cryogen applied as a spray rather than via contact probe)
Cryoprobe / contact cryotherapy(delivery-method subtype — cold delivered through a direct-contact probe)
Cryoneurolysis / cryoanalgesia(pain-medicine subtype — freezing a peripheral nerve to produce reversible analgesia)
Cryoextraction(ophthalmology subtype — historic cataract removal by freezing the lens to a probe)
🔗 RELATED TERMS
Electrocautery — the heat-based counterpart; destroys tissue with electrical current/heat rather than cold. Often a documentation differential when a “destruction” CPT code is selected — the method drives code choice.
Radiofrequency ablation(RFA) — destroys tissue using heat from RF energy; a common alternative to cryoablation for tumors and cardiac arrhythmias; describe the method when both are options.
Cryoablation — shares the cry/o- root; the specifically tumor/tissue-destroying application of cryotherapy (renal, hepatic, prostate, bone, cardiac).
Cryopreservation — shares the cry/o- root but is the opposite intent — cold used to preserve viable cells/tissue (gametes, stem cells), not destroy them.
Liquid nitrogen — the principal cryogen/mechanism; its extreme low temperature (≈ −196 °C) drives the ice-crystal cell destruction.
Cryogenic — adjective describing the very-low-temperature agents and equipment that produce the therapeutic effect.
Necrosis / apoptosis — the cellular endpoint; freezing causes both immediate necrosis (ice-crystal lysis) and delayed apoptosis from ischemia.
Actinic keratosis — a leading dermatologic indication for cryotherapy (premalignant skin lesion; L57.0); commonly treated with liquid nitrogen.
Verruca|Warts (verrucae) — extremely common cryotherapy indication (B07.-); destroyed by freezing.
Cervical dysplasia — gynecologic indication; cryotherapy/cryosurgery of the cervix for low-grade dysplasia (N87.-).
Malignant neoplasm of right kidney, except renal pelvis
C64.2
Malignant neoplasm of left kidney, except renal pelvis
C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
C79.51
Secondary malignant neoplasm of bone
Gynecologic / Ophthalmic / Cardiac Indications
Code
Description
N87.0
Mild cervical dysplasia (CIN I)
N87.1
Moderate cervical dysplasia (CIN II)
H33.30-
Unspecified retinal break (laterality required)
I48.0
Paroxysmal atrial fibrillation
I47.1
Supraventricular tachycardia
⚠️ Coding Note: Because cryotherapy is a procedure, the CPT code is the primary coding axis and the diagnosis (ICD-10-CM) only supports medical necessity — choose the CPT code by method (cryo vs. heat), site, lesion type (benign/premalignant/malignant), and lesion count, since these dimensions split the codes (e.g., 17000/17003/17004 ladder by lesion number; 17110 vs. 17260 by benign vs. malignant). (1) Lesion counting: for premalignant destruction, 17000 covers the first lesion and 17003 is reported per additional lesion (2nd–14th), with 17004 for ≥15 — undercoding happens when multiple actinic keratoses are billed as a single 17000. (2) Sequencing/method: verify documentation states “cryosurgery / cryotherapy / liquid nitrogen / cryoablation” rather than “destruction” alone — many destruction codes are method-agnostic, but image-guided ablation codes (50593, 55873, 20982, 32994) are cryo-specific and require the freezing modality to be documented. (3) Undercoding alert: image guidance is bundled into the percutaneous cryoablation codes (do not separately report ultrasound/CT guidance with 50593/55873/20982/32994); conversely, a documentation phrase like “froze the lesion,” “treated with liquid nitrogen,” or “cryo applied” in an op note should prompt selection of the appropriate destruction/ablation code rather than an E/M-only bill. (4) Payer considerations:whole-body cryotherapy (WBC) and many “cold therapy” wellness services are non-covered/elective — do not append a destruction CPT; cosmetic-lesion destruction may require an ABN. (5) Specificity for authorization: oncologic cryoablation (prostate, renal, lung, bone) typically requires prior authorization with a confirmed malignancy code and tumor size/location documented — capture the staging/site detail to support medical necessity and avoid denial.
Crystal's Coder Hub